RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...

A senior scientist at the US CDC has resigned, warning that changes in leadership may weaken the country’s vaccine program.

The U.S. Centers for Disease Control and Prevention panel of vaccine experts will vote on shots for respiratory syncytial ...

A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...

Moderna's shares fell 2.3% in early trading on Friday, on concerns whether a new CDC advisory panel would back the use of the ...

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...

The 17 members of a federal vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left ...

A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from ...

Kennedy Jr. in the country's top health position, use of a long-approved vaccine against measles, mumps, rubella, and ...

All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying “destabilizing ...

The United States has seen limited supply of Sanofi and AstraZeneca's antibody Beyfortus, the only preventive shot for RSV ...